Trastuzumab: all 614 studies that test it
Page 7 of 7. Open to participants first (88), then studies with results posted, then the rest; newest registration first within each.
- Trastuzumab in Treating Patients With Recurrent OsteosarcomaCompletedNCT00005033Phase 2
- Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2TerminatedNCT00004935Phase 3
- Liposomal Doxorubicin and Trastuzumab in Treating Women With Locally Advanced, Inflammatory, or Metastatic Breast CancerCompletedNCT00004925Phase 1/2
- Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer That Overexpresses HER2CompletedNCT00004883Phase 2
- Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the UrotheliumTerminatedNCT00004856Phase 2
- Trastuzumab in Treating Patients With Advanced Salivary Gland CancerCompletedNCT00004163Phase 2
- Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuCompletedNCT00004074Phase 1
- Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2CompletedNCT00004067Phase 3
- Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast CancerCompletedNCT00004013Phase 2
- Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2CompletedNCT00003995Phase 2
- Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung CancerCompletedNCT00003881Phase 2
- Trastuzumab in Treating Patients With Prostate CancerCompletedNCT00003740Phase 2
- Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast CancerCompletedNCT00003612Phase 2
- Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or MetastaticCompletedNCT00003440Phase 3